Post-Acute Infection Syndromes Will Be the Focus of New YSM Center
The effects of infection don't necessarily end when the first symptoms subside. The new center will work to unravel the mysteries of lingering diseases.
Stay updated with breaking news from Anna Pyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The effects of infection don't necessarily end when the first symptoms subside. The new center will work to unravel the mysteries of lingering diseases.
Yale researchers, using atomic-level Cryo-EM microscopy, have discovered how and why a particular antibiotic is superior to others as a treatment for acne.
Two Yale labs will lead projects, in collaboration with other leading universities, tasked with developing new approaches to understand and combat pathogens.
NZ biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a promising initial development phase.
RIGImmune will utilise the proceeds of the series seed round to further the development of therapeutic oligonucleotides